Search Results - "Farraye, Francis"

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study.

Authors: Itzkowitz, Steven Farraye, Francis A Limburg, Paul J et al.

Source: Journal of Crohn's & Colitis. Sep2023, Vol. 17 Issue 9, p1436-1444. 9p.

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.

Authors: Farraye, Francis A. Qazi, Taha Kotze, Paulo G. et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2021, Vol. 54 Issue 4, p429-440. 12p. 4 Charts, 4 Graphs.

Tertiary referral for double balloon enteroscopy in small bowel Crohn’s disease: a retrospective assessment of diagnostic impact.

Authors: Fluxa, Daniela Saleh, Hasan Karime, Christian et al.

Source: Annals of Gastroenterology. 2025, Vol. 38 Issue 5, p505-510. 6p.

Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease—time for universal recommendation? Authors' reply.

Authors: Caldera, Freddy Spaulding, Aaron C. Hayney, Mary S. et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2023, Vol. 57 Issue 11, p1345-1346. 2p.

Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study.

Authors: Alsakarneh, Saqr Al Ta'ani, Omar Aburumman, Razan et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2025, Vol. 62 Issue 1, p72-76. 5p.

Knowledge, Values, and Preferences Regarding Contraceptive Choices Among Women Living With Inflammatory Bowel Disease.

Authors: Limdi, Jimmy K Rhodes, Sarah Liu, Eleanor et al.

Source: Journal of Crohn's & Colitis. May2025, Vol. 19 Issue 5, p1-9. 9p.

New Onset Inflammatory Bowel Disease Risk Following Bariatric Surgery: A Systematic Review and Meta-Analysis of Observational Studies.

Authors: Aldhaleei, Wafa A. Odah, Tarek Bakheet, Nader et al.

Source: Gastroenterology Insights. Sep2024, Vol. 15 Issue 3, p708-719. 12p.

Gaps in the diagnosis of small bowel adenocarcinoma among patients with Crohn's disease: a tertiary care perspective.

Authors: Zayat, Marisa-Nicole S. Vander Griend, Micah Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 2, p238-246. 9p.

COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.

Authors: Duly, Kristine Farraye, Francis A Bhat, Shubha

Source: American Journal of Health-System Pharmacy. 1/15/2022, Vol. 79 Issue 2, p63-71. 9p. 1 Chart.

MUC1 as a biomarker in primary sclerosing cholangitis and cholangiocarcinoma.

Authors: Hashash, Jana G. Beatty, Pamela Yan, Irene K. et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 1, p48-53. 6p.

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists.

Authors: Susiriwatananont, Thiti Eiamprapaporn, Panuch Vazquez Roque, Maria et al.

Source: Cells (2073-4409). Nov2025, Vol. 14 Issue 22, p1779. 26p.

Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States.

Authors: Desai, Aakash Khataniar, Himsikhar Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2025, Vol. 38 Issue 6, p618-628. 17p.

Epidemiology, risk factors and natural history of eosinophilic esophagitis in patients with inflammatory bowel disease: a population-based cohort study from the United States.

Authors: Kochhar, Gursimran S. Khataniar, Himsikhar Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2025, Vol. 38 Issue 6, p610-617. 9p.

Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.

Authors: Petkovic, Jennifer Riddle, Alison Akl, Elie A. et al.

Source: Systematic Reviews. 2/1/2020, Vol. 9 Issue 1, p1-11. 11p.

'We Need to Take Ownership': ACG Guideline Urges Preventive Care in IBD Management.

Authors: Byrne, Jennifer

Source: Healio Gastroenterology. Aug2025, Vol. 11 Issue 8, p30-32. 2p.

Nintedanib-Induced Colitis Can Mimic Inflammatory Bowel Disease.

Authors: Odah, Tarek Karime, Christian Hashash, Jana G. et al.

Source: ACG Case Reports Journal. Feb2024, Vol. 11 Issue 2, p1-4. 4p.

Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection.

Authors: Motwani, Kiran K Hashash, Jana G Farraye, Francis A et al.

Source: Journal of Crohn's & Colitis. Oct2023, Vol. 17 Issue 10, p1681-1688. 8p.

Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis.

Authors: Kuzhiyanjal, Anish J Kuriakose Nigam, Gaurav B Antoniou, George A et al.

Source: Journal of Crohn's & Colitis. Oct2023, Vol. 17 Issue 10, p1596-1613. 18p.

Efficacy of biologic and small molecule agents as second‐line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity‐matched cohort study.

Authors: Kochhar, Gursimran S. Desai, Aakash Farraye, Francis A. et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2023, Vol. 58 Issue 3, p297-308. 12p. 1 Diagram, 3 Charts, 4 Graphs.

Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S.

Authors: Desai, Aakash Sehgal, Priya Khataniar, Himsikhar et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2025, Vol. 61 Issue 7, p1197-1207. 11p.